UNII 7T1F30V5YH

POLYSORBATE 20

Unique Ingredient Identifier 7T1F30V5YH is listed as a ingredient substance
RN9005-64-5
NCITC80937
RXCUI8559
MFPolymer substance not supported

Alternate Names

Dosage Forms

UNII 7T1F30V5YH POLYSORBATE 20 is commonly included in medications in the following forms.

RouteDosage FormPotency
AURICULAR (OTIC)SUSPENSION, LIQUID0.1 %
IM - SCINJECTION0.001 %
INTRAMUSCULARINJECTABLE16.2 mg/1mL
INTRAMUSCULARINJECTION NA
INTRAMUSCULARINJECTION, SUSPENSION, EXTENDED RELEASE0.5 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.01 %
INTRAMUSCULARSOLUTION, INJECTION0.029 %W/V
INTRAMUSCULARSUSPENSION, EXTENDED RELEASE1 %
INTRAMUSCULARSUSPENSION, INJECTION1.8 %
INTRAVENOUSINJECTABLE10 mg/mL
INTRAVENOUSINJECTION4.8 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION0.044 %
INTRAVENOUSSOLUTION, INJECTION1 %
IV(INFUSION)INJECTABLE0.003 %
IV(INFUSION)INJECTION2.4 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION0.023 %
IV(INFUSION)SOLUTION, INJECTION0.003 %
NASALSPRAY, METERED2.5 %
OPHTHALMICSUSPENSION0.05 %
OPHTHALMICSUSPENSION, DROPS NA
ORALCAPSULE56.25 MG
ORALPOWDER, FOR SUSPENSION1.3 MG/5ML
ORALSOLUTION, ELIXIR NA
ORALSUSPENSION5 MG/1ML
ORALTABLET6 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED0.35 MG
ORALTABLET, COATED NA
ORALTABLET, EXTENDED RELEASE4.2 MG
ORALTABLET, FILM COATED NA
SUBCUTANEOUSINJECTABLE0.003 %
SUBCUTANEOUSINJECTION0.001 %
SUBCUTANEOUSLIQUID0.05 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.01 %
SUBCUTANEOUSSOLUTION, INJECTION0.2 %
TOPICALEMULSION2 %W/W
TOPICALEMULSION, AEROSOL FOAM3.7 %W/W
TOPICALEMULSION, CREAM0.8 %W/W
TOPICALGEL5 %W/W
TOPICALLOTION7.8 %W/W
TOPICALSOLUTION15 %W/W
VAGINALSUPPOSITORY NA
VAGINALTAMPON64.8 MG

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.